Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary
about
Target delineation and optimal radiosurgical dose for pituitary tumors.Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastasesSafety and efficacy of intensity-modulated stereotactic body radiotherapy using helical tomotherapy for lung cancer and lung metastasis.Automating quality assurance of digital linear accelerators using a radioluminescent phosphor coated phantom and optical imaging.The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management.Stereotactic body radiotherapy treatment of extracranial metastases.Stereotactic body radiotherapy: a critical review for nonradiation oncologists.The quality frontier.The development of stereotactic body radiotherapy in the past decade: a global perspective.The role of technology in clinical trials using stereotactic body radiotherapyPoint/Counterpoint. MRI/CT is the future of radiotherapy treatment planning.Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology.A Systematic Analysis of Errors in Target Localization and Treatment Delivery for Stereotactic Radiosurgery Using 2D/3D Image Registration.Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes.Commissioning and initial stereotactic ablative radiotherapy experience with Vero.Prescription to 50-75% isodose line may be optimum for linear accelerator based radiosurgery of cranial lesions.Radiosurgical Treatment Verification Using Removable Megavoltage Radiation Detectors.The impact of technology on the changing practice of lung SBRT.Guidelines for safe practice of stereotactic body (ablative) radiation therapy.Practical considerations of linear accelerator-based frameless extracranial radiosurgery for treatment of occipital neuralgia for nonsurgical candidates.Characteristics of a novel treatment system for linear accelerator-based stereotactic radiosurgery.A prediction model of radiation-induced necrosis for intracranial radiosurgery based on target volume.Results of patient specific quality assurance for patients undergoing stereotactic ablative radiotherapy for lung lesions.Dosimetric effects of immobilization devices on SABR for lung cancer using VMAT technique.AAPM-RSS Medical Physics Practice Guideline 9.a. for SRS-SBRT.Dosimetric effects of immobilization devices on SABR for lung cancer using VMAT technique.
P2860
Q28066872-E2A946B7-F4F1-4900-80DC-4685081ADAF2Q28730322-E4498FC9-81D2-4BC7-8F0F-1C73216F4CBBQ33786992-5E963260-6605-4191-ACAE-EA0A59F21E0DQ36101765-B6B18B9F-012E-4EF2-A42D-743EADB5CB0AQ37175395-C60D65B0-0F8B-463F-990E-68A58A53925CQ38046079-74F360E3-3704-45AD-996E-C12D33CB74C8Q38175120-80CA42C9-05EF-4776-A0FC-54AC9C67E194Q38206272-94274EAD-C706-48CB-889E-63AF6D585033Q38967475-568A7137-BBB9-42D5-A285-5CF1CA31F31DQ39068310-563BC7C7-C5AB-488C-B317-1ADC0D157E89Q39103191-0DE733EC-A57C-4ACC-AC30-5D3C0F8B074CQ39186802-71ED6C8D-0F16-4A92-93A6-B6EE75A5DF8EQ42364898-8D96CF58-5F3C-4CDB-B1B9-A0C631B53BB0Q42857993-C31C059E-4644-45D9-B61B-07F72C90D4FEQ44946517-2BE1D7D4-9422-45DA-9622-60AEA7A1F129Q47147816-198AD55D-F9CA-4984-86FE-8A924873E3E8Q47691782-5D0F0349-C9E6-40CA-9898-DEE307202B05Q47734152-B4D0F0E2-CE94-4BF0-BAC2-99AA7E8B8402Q48165161-89282646-298C-4E2F-B1F7-DF639E9AD4B7Q48603632-9CC175AF-C286-4B65-907D-37B422CC9302Q51830717-30ACE1EF-DF19-41C2-840F-7DFDC69C0217Q52093766-B15D3A2F-D003-4172-A27B-FB969A24D05BQ53083934-BC56D3B0-BA8D-481B-8DCD-2CA719AD232DQ53235364-C70A97A1-DB2E-418D-8F34-07AEFBAE52CBQ53998799-E8193E33-ACF7-4D50-A938-824130243A52Q55424804-02DA68DE-B8AE-4F48-9C5D-0F60F6FD9148
P2860
Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Quality and safety considerati ...... ion therapy: Executive summary
@ast
Quality and safety considerati ...... ion therapy: Executive summary
@en
type
label
Quality and safety considerati ...... ion therapy: Executive summary
@ast
Quality and safety considerati ...... ion therapy: Executive summary
@en
prefLabel
Quality and safety considerati ...... ion therapy: Executive summary
@ast
Quality and safety considerati ...... ion therapy: Executive summary
@en
P2093
P2860
P1476
Quality and safety considerati ...... ion therapy: Executive summary
@en
P2093
Benedick A Fraass
Brian Kavanagh
Curtis Miyamoto
James M Balter
Stanley H Benedict
Timothy D Solberg
Todd Pawlicki
Yoshiya Yamada
P2860
P356
10.1016/J.PRRO.2011.06.014
P577
2011-09-15T00:00:00Z